J GLOB ANTIMICROB RE - Journal of Global Antimicrobial Resistance

Publications

  1. 2023
  2. Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial

    Kurth, F., Helbig, E. T., Lippert, L. J., Thibeault, C., Barbone, G., Eckart, M. A., Kluge, M., Puengel, T., Demir, M., Röhle, R., Keller, T., Ruwwe-Glösenkamp, C., Witzenrath, M., Suttorp, N., von Kalle, C., Sander, L. E., Jochum, C. & Tacke, F., 03.2023, In: J GLOB ANTIMICROB RE. 32, p. 44-47 4 p.

    Research output: SCORING: Contribution to journalShort publicationResearchpeer-review

  3. 2022
  4. Population dynamics in colonizing vancomycin-resistant Enterococcus faecium isolated from immunosuppressed patients

    Both, A., Kruse, F., Mirwald, N., Franke, G., Christner, M., Huang, J., Hansen, J. L., Kröger, N., Berneking, L., Lellek, H., Aepfelbacher, M. & Rohde, H., 03.2022, In: J GLOB ANTIMICROB RE. 28, p. 267-273 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. 2021
  6. In vitro activity of eravacycline, a novel synthetic halogenated tetracycline, against the malaria parasite Plasmodium falciparum

    Koehne, E., Kreidenweiss, A., Adegbite, B. R., Manego, R. Z., McCall, M. B. B., Mombo-Ngoma, G., Adegnika, A. A., Agnandji, S. T., Mordmüller, B. & Held, J., 03.2021, In: J GLOB ANTIMICROB RE. 24, p. 93-97 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review